Skip to Content

Continuing Education

Updates in Small Cell Lung Cancer

Best Suited For: Pharmacist, Pharmacy Technician

CE Credits: 1 hours

Related Topics: Small Cell Lung Cancer (SCLC), Lung Cancer, Bispecific Antibodies, Operational Challenges in Oncology Pharmacy

Description

The goal of this CE activity is to provide an overview of extensive stage small cell lung cancer. It aims to address strategies for preventing myelosuppression associated with etoposide- or topotecan- based chemotherapy. This CE activity will also provide clinical trial data and adverse event management of agents used in the relapsed and refractory setting including lurbinectedin and tarlatamab. Finally, it will discuss important clinical and operational considerations of bispecific T-cell engagers, enhancing participants’ understanding of these therapies.

Pricing

This activity does not require payment to register.

This course has expired.

View our full list of NCODA courses or check the webinar recordings for more to discover.